Step 3: Ongoing Support & Monitoring We will track your progress, guide you in managing any temporary side effects, and adjust your plan to help you stay on track for optimal weight loss
A uniquely formulated product might combine these strains to help you lose weight while keeping your gut happy
It is a clinically proven treatment that helps adults with obesity lose weight while also reducing the risk of cardiovascular events in patients who also have heart disease
Appears to enhance weightloss and glucose effects when combined with GLP1, based on dualagonist data (such as tirzepatide). Glucagon receptor activation Increases energy expenditure and promotes fat oxidation when balanced properly with GLP1 and GIP. May help reduce liver fat and visceral (deep abdominal) fat, which are strongly linked to cardiometabolic risk. By combining these three pathways, retatrutide aims to reduce appetite, improve metabolic control, and increase calorie burning more strongly than current single or dualagonist drugs
Current Evidence: GLP-1 Effects on Rheumatoid Arthritis Symptoms As of 2025, there is limited direct clinical evidence examining the effects of GLP-1 receptor agonists specifically on rheumatoid arthritis symptoms or disease progression
Among these nine classes of drugs, GLP-1RA lowers glycated hemoglobin levels extremely impressive among non-insulin products, and its longer half-life allows it to be administered once a week, or longer
